Recall of AccuVu Angiographic Catheter by Angiodynamics
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Angiodynamics, Inc. is recalling 65 units of the AccuVu Angiographic Catheter due to a manufacturing defect that may prevent guidewires from passing through the catheter hub.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on May 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
Angiodynamics, Inc. is recalling certain AccuVu Angiographic Catheters because of a manufacturing defect that may prevent the appropriately sized guidewire from passing through the inner diameter of the catheter hub.
Which Products Are Affected
The affected products are the AccuVu Angiographic Catheter, Straight Flush, Non-Braided, With 10 R/O Markers; Catalog No.: 13709604; Product/UPN No.: H787137096045 (Box), H787137096040 (Pouch); Box Quantity: 5 pouches; Total quantity: 65 units (13 boxes); Lot No.: A2825044. The distribution includes US Nationwide and countries such as Austria, Australia, Belgium, Canada, China, Chile, Curacao, Czech Republic, Germany, Ireland, Israel, Italy, Lebanon, Netherlands, New Zealand, Panama, Slovenia, South Africa, Spain, Sweden, and Thailand. The official recall number is Z-1873-2026.
What You Should Do
Affected customers should contact Angiodynamics, Inc. as per the initial firm notification via letter for instructions on the recall. The firm is located at 603 Queensbury Ave, Queensbury, NY 12804-7619.
Why This Matters
This recall involves medical devices that could impact procedures if the defect occurs, potentially leading to complications, though the risk is classified as Class II by the FDA.
Source
This information is from the FDA recall database, recall number Z-1873-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,361 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to May 7, 2026.
Frequently Asked Questions
Common questions about this FDA recall.